↓ Skip to main content

Multicenter experience in hematopoietic stem cell transplantation for serious complications of common variable immunodeficiency

Overview of attention for article published in The Journal of Allergy and Clinical Immunology, January 2015
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (51st percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
5 X users
facebook
1 Facebook page

Citations

dimensions_citation
118 Dimensions

Readers on

mendeley
110 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Multicenter experience in hematopoietic stem cell transplantation for serious complications of common variable immunodeficiency
Published in
The Journal of Allergy and Clinical Immunology, January 2015
DOI 10.1016/j.jaci.2014.11.029
Pubmed ID
Authors

Claudia Wehr, Andrew R. Gennery, Caroline Lindemans, Ansgar Schulz, Manfred Hoenig, Reinhard Marks, Mike Recher, Bernd Gruhn, Andreas Holbro, Ingmar Heijnen, Deborah Meyer, Goetz Grigoleit, Hermann Einsele, Ulrich Baumann, Thorsten Witte, Karl-Walter Sykora, Sigune Goldacker, Lorena Regairaz, Serap Aksoylar, Ömur Ardeniz, Marco Zecca, Przemyslaw Zdziarski, Isabelle Meyts, Susanne Matthes-Martin, Kohsuke Imai, Chikako Kamae, Adele Fielding, Suranjith Seneviratne, Nizar Mahlaoui, Mary A. Slatter, Tayfun Güngör, Peter D. Arkwright, Joris van Montfrans, Kathleen E. Sullivan, Bodo Grimbacher, Andrew Cant, Hans-Hartmut Peter, Juergen Finke, H. Bobby Gaspar, Klaus Warnatz, Marta Rizzi, Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation and the European Society for Immunodeficiency

Abstract

Common variable immunodeficiency (CVID) is usually well controlled with immunoglobulin substitution and immunomodulatory drugs. A subgroup of patients has a complicated disease course with high mortality. For these patients, investigation of more invasive, potentially curative treatments, such as allogeneic hematopoietic stem cell transplantation (HSCT), is warranted.

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 110 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
Spain 1 <1%
Unknown 108 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 14 13%
Student > Ph. D. Student 13 12%
Other 11 10%
Student > Bachelor 10 9%
Student > Doctoral Student 10 9%
Other 28 25%
Unknown 24 22%
Readers by discipline Count As %
Medicine and Dentistry 45 41%
Immunology and Microbiology 11 10%
Agricultural and Biological Sciences 10 9%
Biochemistry, Genetics and Molecular Biology 5 5%
Psychology 2 2%
Other 7 6%
Unknown 30 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 June 2015.
All research outputs
#14,300,634
of 25,411,814 outputs
Outputs from The Journal of Allergy and Clinical Immunology
#8,559
of 11,258 outputs
Outputs of similar age
#174,498
of 361,155 outputs
Outputs of similar age from The Journal of Allergy and Clinical Immunology
#110
of 179 outputs
Altmetric has tracked 25,411,814 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 11,258 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 17.7. This one is in the 23rd percentile – i.e., 23% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 361,155 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 51% of its contemporaries.
We're also able to compare this research output to 179 others from the same source and published within six weeks on either side of this one. This one is in the 38th percentile – i.e., 38% of its contemporaries scored the same or lower than it.